IQVIA™ Pharma Deals: PharmaDeals Review: Table of Contents

<< Previous Issue

Mar 2023 (Vol: 2023, Issue: 3)

Section: Licensing
Eli Lilly Licenses Non-Opioid Pain Drug from Confo Therapeutics Published: 8 Mar-2023
By: Lucy Haggerty
Abstract Fulltext:
ImmunoGen Signs Partnership with Vertex for Conditioning Agents worth US$352 M Published: 28 Mar-2023
By: Swati Sharan
Abstract Fulltext:
Section: Mergers & Acquisitions
Pfizer to Acquire ADC Cancer Specialist Seagen for US$43 B Published: 15 Mar-2023
By: Lucy Haggerty
Abstract Fulltext:
Sanofi Buys Provention Bio and its Type 1 Diabetes Drug for US$2.9 B Published: 24 Mar-2023
By: Lucy Haggerty
Abstract Fulltext:
Adaptimmune and TCR2 Merge to Form a Solid Tumour Company Published: 28 Mar-2023
By: Shweta Gupta & Lucy Haggerty
Abstract Fulltext:
Section: Opinion & Analysis
IQVIA Pharma Deals Review of 2022 Published: 15 Mar-2023
By: Heather Cartwright, Taskin Ahmed & Lucy Haggerty
Abstract Fulltext:
Section: Research & Development
Merck Signs US$922.5 M Collaboration with OPKO Health for Epstein-Barr Virus Vaccine Published: 17 Mar-2023
By: Lalit Mishra & Lucy Haggerty
Abstract Fulltext:
BioNTech Collaborates with OncoC4 to Co-Develop CTLA-4 Cancer Antibody Published: 24 Mar-2023
By: Ayush Saxena
Abstract Fulltext:
UCB Enters into Drug Discovery Collaboration with Aitia for Huntington’s Disease Published: 29 Mar-2023
By: Ashish Tripathi
Abstract Fulltext:

Login

Username:

Password:

Keep me logged in